Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a blood clot in a deep vein (DVT) along with a significant narrowing (more than 50%) in the vein in your hip/pelvis area on the same side, either caused by vein compression or leftover clot after a clot-removal procedure.
- You have had a mechanical clot-removal procedure (a procedure using a device to physically remove the blood clot), with or without a separate treatment that dissolves clots through a thin tube.
- You have had a stent (a small mesh tube to keep the vein open) placed in your hip/pelvis vein either during or within 30 days of your clot-removal procedure.
Who may not be able to join:
- Your blood clot has been present for longer than 3 weeks, or is considered a long-term (chronic) clot.
- Your blood clot is only in the smaller veins below the knee and does not affect the main veins in your thigh or hip/pelvis area.
- Your kidneys are not working well enough (based on a specific kidney function test result) (confirm with trial site).
- You had varicose veins or existing vein problems on the same side before your blood clot, such as skin discolouration, swelling, hardened skin, or leg ulcers.
- You have a sudden blockage in an artery on either side, or a known significant narrowing in the main artery in your abdomen or the arteries in your hip or leg on the same side.
- You have a known bulge (aneurysm) or a serious tear in the wall of the main abdominal artery or the arteries in your hip or leg on the same side.
- You cannot take blood-thinning or anti-clotting medications due to a medical reason.
- You have a serious ongoing illness or condition that cannot be managed with current treatments.
- You were already taking blood-thinning or anti-clotting medications for another condition before your blood clot developed.
- You are under 18 years old, or you do not wish to participate in the study.
- You have had a heart attack in the past 6 months.
- You are considered at high risk of bleeding — this includes people with a history of bleeding in the brain, stroke, other brain conditions, recent stomach or bowel bleeding, liver failure, a blood-clotting disorder, very advanced age or frailty, or severe kidney failure requiring dialysis.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hongkun Zhang, M.D., First Affiliated Hospital of Zhejiang University
Phone: 0571-87236745
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Effectiveness Endpoints; Primary Safety Endpoints
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.